Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048376036> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2048376036 endingPage "2085" @default.
- W2048376036 startingPage "2077" @default.
- W2048376036 abstract "The presence of steatosis and inflammatory infiltrate in liver biopsies is essential for the diagnosis of non-alcoholic steatohepatitis (NASH). These findings are similar to those with alcoholic liver disease. However, in the NASH-situation alcohol doesn't play an important role. Risk factors for the development of NASH are obesity and diabetes. Most of the patients are clinically asymptomatic. This means, that a diagnosis of NASH is a diagnosis of exclusion: Viral induced, autoimmune, metabolic and toxic liver disease have to be excluded. The disease has a benign clinical course. The risk of cirrhosis is low. So far, there is no established treatment. Preliminary reports suggest a positive effect of weight-loss and ursodeoxycholic acid. Wilson's disease, a copper storage disorder, in which biliary copper excretion is reduced, is inherited as an autosomal recessive trait. Most patients with Wilson disease become symptomatic between the ages of 6 and 15. In about 90% of patients serum ceruloplasmin levels and serum copper concentrations are reduced. Copper excreation is increased. Histologic examination of liver biopsy specimens reveals fatty infiltration, Mallory bodies and ballooned glycogen nuclei, abnormalities which are also found in alcoholic liver disease. The definitive diagnostic parameter is the quantitative determination of liver copper content (> 250 micrograms/g dryweight). Untreated Wilson disease is always fatal. Lifelong treatment with anti-copper drugs are essential, D-penicillamine being the firstline therapy. Hereditary hemochromatosis (HH) is an iron overload disease inherited as an autosomal recessive trait. The frequency of the disease is high. The first symptoms usually can be found at the age of 20-50 years. Arthralgia develops in up to 50% of the patients. Many organs are involved, most often the liver. The organ is usually enlarged, transaminases are always moderately elevated. Laboratory findings disclose a marked elevation in serum ferritin and transferrin saturation. More than 80% of HH-patients are homozygous for the C282Y-mutation in the HFE-gene. The firstline treatment of HH is phlebotomy. Treatment is lifelong. When serum ferritin drops below 50 micrograms/l, the frequency of phlebotomy should be reduced (4-12 per year). If the patient already has cirrhosis, the risk of HCC is very high." @default.
- W2048376036 created "2016-06-24" @default.
- W2048376036 creator A5020492971 @default.
- W2048376036 date "2002-11-27" @default.
- W2048376036 modified "2023-09-23" @default.
- W2048376036 title "[Rare, but important chronic liver diseases]." @default.
- W2048376036 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12508671" @default.
- W2048376036 hasPublicationYear "2002" @default.
- W2048376036 type Work @default.
- W2048376036 sameAs 2048376036 @default.
- W2048376036 citedByCount "0" @default.
- W2048376036 crossrefType "journal-article" @default.
- W2048376036 hasAuthorship W2048376036A5020492971 @default.
- W2048376036 hasConcept C126322002 @default.
- W2048376036 hasConcept C142724271 @default.
- W2048376036 hasConcept C2775934546 @default.
- W2048376036 hasConcept C2776590208 @default.
- W2048376036 hasConcept C2777214474 @default.
- W2048376036 hasConcept C2777575235 @default.
- W2048376036 hasConcept C2777766500 @default.
- W2048376036 hasConcept C2777910003 @default.
- W2048376036 hasConcept C2778772119 @default.
- W2048376036 hasConcept C2779134260 @default.
- W2048376036 hasConcept C2779478299 @default.
- W2048376036 hasConcept C3018783601 @default.
- W2048376036 hasConcept C71924100 @default.
- W2048376036 hasConcept C90924648 @default.
- W2048376036 hasConceptScore W2048376036C126322002 @default.
- W2048376036 hasConceptScore W2048376036C142724271 @default.
- W2048376036 hasConceptScore W2048376036C2775934546 @default.
- W2048376036 hasConceptScore W2048376036C2776590208 @default.
- W2048376036 hasConceptScore W2048376036C2777214474 @default.
- W2048376036 hasConceptScore W2048376036C2777575235 @default.
- W2048376036 hasConceptScore W2048376036C2777766500 @default.
- W2048376036 hasConceptScore W2048376036C2777910003 @default.
- W2048376036 hasConceptScore W2048376036C2778772119 @default.
- W2048376036 hasConceptScore W2048376036C2779134260 @default.
- W2048376036 hasConceptScore W2048376036C2779478299 @default.
- W2048376036 hasConceptScore W2048376036C3018783601 @default.
- W2048376036 hasConceptScore W2048376036C71924100 @default.
- W2048376036 hasConceptScore W2048376036C90924648 @default.
- W2048376036 hasIssue "48" @default.
- W2048376036 hasOpenAccess W2048376036 @default.
- W2048376036 hasRelatedWork W129947870 @default.
- W2048376036 hasRelatedWork W159593941 @default.
- W2048376036 hasRelatedWork W1922187626 @default.
- W2048376036 hasRelatedWork W1992226184 @default.
- W2048376036 hasRelatedWork W1995857646 @default.
- W2048376036 hasRelatedWork W2012361078 @default.
- W2048376036 hasRelatedWork W2035776627 @default.
- W2048376036 hasRelatedWork W2049119936 @default.
- W2048376036 hasRelatedWork W2067644555 @default.
- W2048376036 hasRelatedWork W2071420305 @default.
- W2048376036 hasRelatedWork W2077344442 @default.
- W2048376036 hasRelatedWork W2107779263 @default.
- W2048376036 hasRelatedWork W2169595978 @default.
- W2048376036 hasRelatedWork W2320391281 @default.
- W2048376036 hasRelatedWork W2395953718 @default.
- W2048376036 hasRelatedWork W2401424271 @default.
- W2048376036 hasRelatedWork W2405882186 @default.
- W2048376036 hasRelatedWork W2563118732 @default.
- W2048376036 hasRelatedWork W2607031172 @default.
- W2048376036 hasRelatedWork W47333012 @default.
- W2048376036 hasVolume "91" @default.
- W2048376036 isParatext "false" @default.
- W2048376036 isRetracted "false" @default.
- W2048376036 magId "2048376036" @default.
- W2048376036 workType "article" @default.